Merck

Type
Internal restructuring
Country
Italy
Region
Location of affected unit(s)
Sector
Manufacturing
(20 - 21) Manufacture of chemicals and pharmaceuticals
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
21.10 - Manufacture of basic pharmaceutical products
243 jobs
Number of planned job losses
Job loss
Announcement Date
3 October 2013
Employment effect (start)
30 November 2013
Foreseen end date

Description

The Italian subsidiary Merck Sharp and Dohme (MSD) of world-wide operating pharmaceutical group Merck is to cut 243 jobs. It was announced that cuts will mostly affect sales representatives.

The trade unions reacted to the company’s decision by organizing worker protests.

Merck is based in Whitehouse Station (New Jersey, US) and employs over 80,000 staff worldwide. The main part of the Italian workforce (around 1,000 workers) is employed in a site located in Rome.

Earlier in 2013, MSD already closed a site in Pavia (northerly Italy), making 270 staff redundant.

The group has recently announced a global restructuring plan.

Sources

  • 4 October 2013: Newsit24.it

Citation

Eurofound (2013), Merck, Internal restructuring in Italy, factsheet number 76005, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/76005.